Search by Drug Name or NDC

    NDC 00169-4060-99 Victoza 6 mg/mL Details

    Victoza 6 mg/mL

    Victoza is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is LIRAGLUTIDE.

    Product Information

    NDC 00169-4060
    Product ID 0169-4060_fbacd7b4-2565-4292-b1f6-2aff4e467d47
    Associated GPIs 2717005000D220
    GCN Sequence Number 065344
    GCN Sequence Number Description liraglutide PEN INJCTR 0.6 MG/0.1 SUBCUT
    HIC3 C4I
    HIC3 Description ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)
    GCN 26189
    HICL Sequence Number 036436
    HICL Sequence Number Description LIRAGLUTIDE
    Brand/Generic Brand
    Proprietary Name Victoza
    Proprietary Name Suffix n/a
    Non-Proprietary Name liraglutide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 6
    Active Ingredient Units mg/mL
    Substance Name LIRAGLUTIDE
    Labeler Name Novo Nordisk
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022341
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-4060-99 (00169406099)

    NDC Package Code 0169-4060-99
    Billing NDC 00169406099
    Package 1 SYRINGE, PLASTIC in 1 CARTON (0169-4060-99) / 3 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2015-02-13
    NDC Exclude Flag N
    Pricing Information N/A